| | | | | | What you need to know about the coronavirus today | | | Intensive care body advises against remdesivir for sickest Antiviral remdesivir should not be used as a routine treatment for patients in critical care wards, the head of one of the world’s top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead. Remdesivir and steroid dexamethasone are the only drugs authorized to treat COVID-19 patients across the world. But the largest study on remdesivir’s efficacy, run by the World Health Organization, showed it had little or no impact, contradicting previous trials.
China finds virus on packaging of Brazilian beef The Chinese city of Wuhan said it had detected the novel coronavirus on the packaging of a batch of Brazilian beef, as it ramped up testing of frozen foods this week as part of a nationwide campaign. After taking drastic measures to control the spread of the virus in the population this year, China began in late June to test imported food for the virus too.
Congressman who ridiculed virus now says he has it The Alaska congressman who once ridiculed the seriousness of the novel coronavirus, calling it the “beer virus”, said he is now infected with it. The announcement by Representative Don Young comes as the state’s governor warned that healthcare and public safety systems were at risk of being overwhelmed by the rapid spread of the virus across Alaska.
Musk questions coronavirus tests Tesla Chief Executive Officer Elon Musk questioned the accuracy of COVID-19 tests after claiming that results showed he tested positive twice and then negative twice all on the same day. “Something extremely bogus is going on. Was tested for COVID four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD,” Musk said in a tweet, possibly referring to Becton, Dickinson and Company’s rapid antigen test. | | | | From Breakingviews - Corona Capital: Pinduoduo, Thyssenkrupp, WeWork. China’s Pinduoduo, the Groupon-meets-Facebook deals app, is on a roll amid the pandemic, Thyssenkrupp warms to hydrogen and WeWork's cash burn may require more SoftBank help. Catch up with the latest pandemic-related financial insights. | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |